EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RCBTB2 in cancer: context-dependent functions and translational boundaries

Chuanhai Cai, Jianjun Du, Liga Tu, Wei Li, Ren Mo

Frontiers in Oncology · 17.08.2026 · 16

DOI: 10.3389/fonc.2026.1947868 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 17.08.2026. Verfasst von Chuanhai Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School, Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RCBTB2 (RCC1 and BTB domain-containing protein 2), located at chromosome 13q14, is affected by deletion, amplification, expression change, or gene fusion across the cancers studied to date. The divergent directions of these alterations do not fit a tumor-suppressor model with a fixed direction of action. Here, genetic, transcriptomic, protein-level, and functional evidence is integrated across reported cancer contexts and interpreted through three layers: the genomic neighbourhood, cell lineage, and signalling or cellular state. Within this model, the 13q14 neighbourhood determines whether RCBTB2 is altered independently or alongside genes such as RB1. Its functional consequences are further constrained by lineage-specific networks and may vary with proteostatic and ciliary states. Direct evidence connects RCBTB2 with GPAA1-related proteostasis in prostate cancer and primary ciliogenesis in mammalian cells. The proposed link between altered ciliogenesis and Hedgehog signalling in SHH medulloblastoma, however, has not been tested. On current evidence, RCBTB2 merits evaluation as a context-dependent classification or prognostic candidate, not as a broadly applicable therapeutic target. Resolving gene-specific effects within 13q14, testing cross-lineage interactions, and measuring incremental clinical value in independent cohorts are therefore the immediate priorities.

Schlagwörter

Stichwörter der Autor:innen

RCBTB2biomarkercopy-number alterationmolecular classificationprimary ciliumtumor heterogeneity

Autor:innen und Institutionen

  • Graduate School, Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, China.
  • Department of Urology, Inner Mongolia People's Hospital, Inner Mongolia Urological Institute, Hohhot, China.

Zitieren

APA

Cai, C., Du, J., Tu, L., Li, W., & Mo, R. (2026). RCBTB2 in cancer: context-dependent functions and translational boundaries. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1947868

Vancouver

Cai C, Du J, Tu L, Li W, Mo R. RCBTB2 in cancer: context-dependent functions and translational boundaries. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1947868

BibTeX
@article{Cai2026,
  author = {Cai, Chuanhai and Du, Jianjun and Tu, Liga and Li, Wei and Mo, Ren},
  title = {RCBTB2 in cancer: context-dependent functions and translational boundaries},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1947868}
}
Kostenlos starten →